Vineet Laboratories LimitedVINEETLABNSEHealthcare

Rights Issue

27 Nov 2025 · 12:46 ISTCapitalWatchNotable

What happened

Fact

Ten Only) each for an aggregate amount not exceeding Rs.3,000 Lakhs (Rupees Three. Constitution of the Rights Issue Committee, consisting of Mr. Gaddam Venkata Ramana. the proposed Rights Issue.

Why it matters

CapitSignal interpretation

Existing holders can maintain their stake only by putting in more money; those who do not subscribe are diluted.

Watch next

Fact

Rights ratio and issue price
Record date and subscription window
Promoter intention to subscribe

Evidence

The Board of Directors of Vineet Laboratories Limited at its meeting held today i.e., on Thursday, November 27, 2025, approved the following:1. Raise of funds by way of issue of equity shares of the Company of face value Rs.10/- (RupeeTen Only) each for an aggregate amount not exceeding Rs.3,000 Lakhs (Rupees ThreeThousand Lakhs) on Right issue basis, on such terms and conditions as may be decided bythe Board of Directors / Rights Issue Committee to the eligible equity shareholders of theCompany, as on the record date (to be notified subsequently).The issue is subject to the receipt of applicable regulatory, statutory approvals, inaccordance with the provisions of the Securities and Exchange Board of India (Issue ofCapital and Disclosure Requirements) Regulations, 2018, Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements), Regulations, 2015, and theCompanies Act, 2013 and the rules made thereunder, as amended from time to time.2. Constitution of the Rights Issue Committee, consisting of Mr. Gaddam Venkata Ramana,Mr. Satyanarayana Raju Bhupathiraju, Mr. Premananda Reddy Vennapusa, Mr. Dilip VishnuAcharekar empowering them to undertake all the necessary activities for the completion ofthe proposed Rights Issue.

How CapitSignal classified this

Reasoning:: RIGHTS_ISSUE base 64; +5 quantified amount; matched on subject
Matched on:: the filing's own subject line
Confidence in the event type:: 75%

See Vineet Laboratories Limited’s full corporate memory →